MHRA unveils ‘innovation passport’ for new medicines

A licensing pathway that will reduce the time it takes for novel medicines to enter the marketplace has been launched by the UK Medicines and Healthcare products Regulatory Agency (MHRA).

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

MHRA conducts operation into counterfeit medicines

16 May 2016 The UK government’s Medicines and Healthcare Products Regulatory Agency has conducted an operation into counterfeit and unlicensed erectile dysfunction medicines across London.

Europe

Counterfeit drug sites stung in MHRA operation

13 January 2015 UK regulatory body the Medicines and Healthcare and Products Regulatory Agency has successfully taken down more than 1,600 websites, some of which were selling counterfeit drugs.

More features

The Quintara decision: Defining trade secrets in federal cases

To disclose or not: Pharma patents face new AI reality

Trade secrets go global: How brand owners face a high-stakes battlefront

Killing the golden goose of US drug innovation (Part II): Drug pricing myths

Former pharma GC brings in-house perspective to McGuireWoods

Sandoz eyes US biosimilar launch as Regeneron settles

Killing the golden goose of US drug innovation (Part I): Follow the money

Buchalter brings in new partner to head up medtech

MHRA unveils ‘innovation passport’ for new medicines

More on this story

Editor's picks

Editor's picks

More features